According to a new report Global Cephalosporin Drugs Market, published by KBV Research, The Global Cephalosporin Drugs Market size is expected to reach $14.1 billion by 2025, rising at a market growth of 3.34% CAGR during the forecast period.

The Third-Generation Cephalosporin Drugs market dominated the Global Cephalosporin Drugs Market by Generation in 2018, growing at a CAGR of 3.6 % during the forecast period. The Second-Generation Cephalosporin Drugs market is expected to witness a CAGR of 3.2% during (2019-2025).

The Injections market dominated the Global Cephalosporin Drugs Market by Route of Administration in 2018, growing at a CAGR of 3.3 % during the forecast period. The Oral Drugs market is expected to witness a CAGR of 3.5% during (2019-2025).

The Asia Pacific market dominated the Global Skin Infection Market by Region in 2018, growing at a CAGR of 3.1 % during the forecast period. The Europe market is expected to witness a CAGR of 3.3% during (2019-2025). Additionally, The North America market is expected to witness a CAGR of 5.1% during (2019-2025).

Full Report: https://www.kbvresearch.com/cephalosporin-drugs-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT Laboratories, Teva Pharmaceuticals Industries Ltd., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, Baxter International, Inc., Bristol-Myers Squibb Company and Novartis AG.

Global Cephalosporin Drugs Market Segmentation

By Generation

First-Generation Cephalosporin
Second-Generation Cephalosporin
Third-Generation Cephalosporin
Fourth-Generation Cephalosporin
Fifth-Generation Cephalosporin

By Application

Respiratory Tract Infection
Skin Infection
Ear Infection
Sexually Transmitted Infection
Others

By Route of Administration

Injections
Oral Drugs

By Type

Branded
Generic

By Geography

North America

US
Canada
Mexico
Rest of North America

Europe

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Asia Pacific

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

LAMEA

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Companies Profiled

ABBOTT Laboratories
Teva Pharmaceuticals Industries Ltd.
Johnson and Johnson
GlaxoSmithKline PLC (GSK)
Pfizer, Inc.
Merck & Co., Inc.
Bayer AG
Baxter International, Inc.
BRISTOL-MYERS SQUIBB COMPANY
Novartis AG

Cephalosporin Drugs Market Related Reports:

North America Market
Europe Market
Asia Pacific Market
LAMEA Market